Ross Hockenbury, MD
Orthopaedic Surgery · Louisville, KYNPI 1629099528
Payments from drug & device makers
Across 208 payments — averaging $71.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$11K
- Vilex LLC$1K
- Smith+Nephew$637
- Alpha Orthopedic Systems$563
- Medline Industries LP$364
- Bioventus LLC$104
- plus $581 from 15 others
What the payments were for
- Travel & lodging$4,51930%
- Food & beverage$9,35463%
- Education$9807%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 132 | $11,265 |
| Vilex LLC | 11 | $1,338 |
| Smith+Nephew | 37 | $637 |
| Alpha Orthopedic Systems | 3 | $563 |
| Medline Industries LP | 2 | $364 |
| Bioventus LLC | 3 | $104 |
| Arteriocyte Medical Systems, Inc. | 1 | $103 |
| Kerecis Limited | 3 | $84 |
| Treace Medical Concepts, Inc. | 1 | $80 |
| Sanara Medtech Inc. | 2 | $68 |
| Zimmer Biomet | 1 | $39 |
| Paragon 28, Inc. | 2 | $36 |
| Aroa Biosurgery Incorporated | 2 | $32 |
| Medtronic | 1 | $23 |
| Lifenet Health | 1 | $22 |
| Orthofix Medical, Inc. | 1 | $20 |
| Integra Lifesciences Corporation | 1 | $19 |
| Vertex | 1 | $16 |
| Organogenesis Inc. | 1 | $14 |
| Pfizer | 1 | $13 |
| Ferring Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFINITY$2,178
- INBONE$2,019
- AUGMENT INJECTABLE$981
- TAR$928
- PROPHECY$706
- STAR$599
- PROstep$534
- VALOR$443
- EASYFUSE$428
- ORTHOLOC 3DI CROSSCHECK$279
- ORTHOLOC$190
- MAXTORQUE$156
- Foot and Ankle$155
- Viaflow$149
- JII Unicondylar Knee System$148
- PRIME SERIES$123
- G-FORCE$123
- FUSEFORCE$121
- ORTHOLOC 3DI$119
- Magellan$103
How this compares
$14,854 in reported general payments places this provider in the 70th percentile of 322 orthopaedic surgery providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 48 | $662 |
| Cephalexin | 37 | $473 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 27 | $215 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 32 | $196 |
| Pregabalin | 12 | $177 |
| Clindamycin Hcl | 17 | $140 |
| Ropinirole Hcl | 14 | $84 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $64 |
| Terbinafine Hcl | 13 | $38 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Louisville
- Arthur MalkaniLouisville$9.9M
- Jonathan YerasimidesLouisville$4.3M
- John LewisLouisville$1.6M
- Akbar NawabLouisville$1M
- Joseph GreeneLouisville$584K
- Rodolfo Zamora RendichLouisville$539K
- Tyler KellerLouisville$401K
- Madhusudhan YakkantiLouisville$360K
- Kevin HarreldLouisville$313K
- George QuillLouisville$304K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.